AzTrials
AzTrials

Contact LensNCT02713399

High-resolution Imaging of Tear Film Thickness in Contact Lenses Wearers With Optical Coherence Tomography (OCT). A Pilot Study

An observational study of Contact Lens and Tear Film Thickness, run by Medical University of Vienna at 1 site in Austria.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

A refractive error is the most common reason for reduced visual acuity. Myopia, hyperopia, astigmatism and presbyopia belong to the four basic refractive errors and, unfortunately, cannot be prevented. There are different tools to correct them, like spectacles, contact lenses, and refractive surgery. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Contact Lens, Tear Film Thickness
What is being tested?
Optical Coherence Tomography
Type of treatment
Medical device
How many people
30 participants
Where
1 siteAustria
Study dates
16 Mar 2016to Nov 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: 15 soft contact lens wearers 15 rigid contact lens wearers

Who may be able to join

  • Men and women aged over 18 years
  • Soft or rigid contact lenses wearers
  • Schirmer Test ≥ 10 mm/5 min
  • Tear Breakup Time (TBUT) ≥10 seconds

Who cannot join

  • Participation in a clinical trial in the previous 3 weeks
  • Presence of any abnormalities preventing reliable measurements as judged by the investigator
  • Pregnancy, planned pregnancy or lactating

Trial locations and contacts

1 site in 1 country.

Gerhard Garhöfer, Assoc. Prof. PD Dr. contact

+43 1 4040029880

gerhard.garhoefer@meduniwien.ac.at

Austria1 site, 1 recruiting
  • Department of Clinical Pharmacology, Medical University of Vienna

    Vienna, 1090

    Gerhard Garhöfer, Assoc. Prof. PD Dr., +43 (1) 40400 ext. 29810, gerhard.garhoefer@meduniwien.ac.at

    Piotr A Wozniak, MD

    Recruiting

Other trials in Austria

About this study

A refractive error is the most common reason for reduced visual acuity. Myopia, hyperopia, astigmatism and presbyopia belong to the four basic refractive errors and, unfortunately, cannot be prevented. There are different tools to correct them, like spectacles, contact lenses, and refractive surgery. Many different contact lenses are available, the two large groups create rigid contact lenses and soft contact lenses. It is a common knowledge that the presence of a contact lens in the eye divides the tear film into the prelens and postlens tear film layers. In the present study we want to investigate the variability and reproducibility of prelens and postlens tear film thickness measurements.

Being tested
Optical Coherence Tomography

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Optical Coherence TomographyDevice

Study groups in NCT02713399
Study groupRoleWhat they receive
Soft Contact Lenseshealthy subjects wearing soft contact lenses
Receives: Device: Optical Coherence Tomography
Rigid Contact Lenseshealthy subjects wearing rigid contact lenses
Receives: Device: Optical Coherence Tomography

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pre lens and post lens tear film thickness

    Measured: 2 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Mar 2016 (estimated)
  2. Study start16 Mar 2016
  3. Primary completionSep 2023 (estimated)
  4. Study completionNov 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02713399
Sponsor's protocol ID
OPHT-150116
Status last verified
Apr 2022
First submitted
15 Mar 2016
Last updated
7 Apr 2022
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Contact Lens and Tear Film Thickness, run by Medical University of Vienna at 1 site in Austria.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 7 Apr 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Austria. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Gerhard Garhöfer, Assoc. Prof. PD Dr. (+43 1 4040029880, gerhard.garhoefer@meduniwien.ac.at), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pre lens and post lens tear film thickness (time frame: 2 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Apr 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in